Review decision – April 2016
SonoVue (sulphur hexafluoride microbubbles) – contrast agent for contrast-enhanced ultrasound imaging of the liver: review decision
Review of NICE diagnostics guidance 5; SonoVue (sulphur hexafluoride microbubbles) – contrast agent for contrast-enhanced ultrasound imaging of the liver
Decision to move the existing guidance to the static list.
The Institute was proposing to transfer the guidance to the ‘static guidance list’ and signpost users from the landing page to the evidence which addresses the research recommendations.
During consultation, the majority of comments received by the Institute agreed with the proposal put forward. After consideration of all of the comments, the Institute’s Guidance Executive has decided to proceed with the proposal.
This page was last updated: